Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 10:17 PM
Ignite Modification Date:
2025-12-25 @ 7:51 PM
NCT ID:
NCT00913835
Group ID:
EG001
Title:
Liposomal Doxorubicin
Description:
40 mg/m² of liposomal doxorubicin was administered according to the manufacturer's instructions every 4 weeks (28 days). Treatment continued until there was evidence of PD or development of unacceptable toxicity up to 130 weeks.
Upon disease progression the participant had the option to receive Olaratumab monotherapy.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
23
Serious Number At Risk:
61
Other Number Affected:
60
Other Number At Risk:
61
Study:
NCT00913835
Results Section:
NCT00913835
Adverse Events Module:
NCT00913835